INOVIO PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of GBM for the last quarter is 0.00 EUR, and it's 100.00% lower compared to the previous quarter. The net income of Q1 24 is -28.24 M EUR.